AU7613594A - Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments - Google Patents

Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments

Info

Publication number
AU7613594A
AU7613594A AU76135/94A AU7613594A AU7613594A AU 7613594 A AU7613594 A AU 7613594A AU 76135/94 A AU76135/94 A AU 76135/94A AU 7613594 A AU7613594 A AU 7613594A AU 7613594 A AU7613594 A AU 7613594A
Authority
AU
Australia
Prior art keywords
alkylated
medicaments
dicarboxylic acid
acid esters
dihydropyridine dicarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76135/94A
Other languages
English (en)
Inventor
Siegfried Goldmann
Dieter Neuser
Johannes-Peter Stasch
Siegfried Zaiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU7613594A publication Critical patent/AU7613594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76135/94A 1993-08-27 1994-08-16 Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments Abandoned AU7613594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4328884 1993-08-27
DE4328884A DE4328884A1 (de) 1993-08-27 1993-08-27 Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
PCT/EP1994/002723 WO1995005823A1 (de) 1993-08-27 1994-08-16 Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsäureestern als arzneimittel

Publications (1)

Publication Number Publication Date
AU7613594A true AU7613594A (en) 1995-03-21

Family

ID=6496196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76135/94A Abandoned AU7613594A (en) 1993-08-27 1994-08-16 Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments

Country Status (13)

Country Link
EP (1) EP0714301A1 (de)
JP (1) JPH09501923A (de)
KR (1) KR960703594A (de)
CN (1) CN1129906A (de)
AU (1) AU7613594A (de)
BG (1) BG100367A (de)
CA (1) CA2170285A1 (de)
CZ (1) CZ43896A3 (de)
DE (1) DE4328884A1 (de)
HU (1) HUT75302A (de)
NO (1) NO960777L (de)
PL (1) PL313116A1 (de)
WO (1) WO1995005823A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741694C2 (de) * 1997-09-18 2002-10-31 Schering Ag Verwendung von Komplexen, deren Ligand ein Bis-Amin-Oxim-Derivat oder ein N¶2¶S¶2¶-Derivat und deren Zentralatom ein Radionuklid ist
ES2271365T3 (es) 2001-12-20 2007-04-16 Bayer Healthcare Ag Derivados de 1,4-dihidro-1,4-difenilpiridina.
US10258498B2 (en) * 2011-11-24 2019-04-16 Richter Gedeon Nyrt. 1,4-dihydropyridine derivatives with Hsp modulating activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
EP0169009A3 (de) * 1984-07-17 1988-08-31 FISONS plc Dihydropyridinderivate und ihre Herstellung, Formulierung und Verwendung als Pharmazeutika
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPH09501923A (ja) 1997-02-25
HUT75302A (en) 1997-05-28
WO1995005823A1 (de) 1995-03-02
HU9600472D0 (en) 1996-04-29
CA2170285A1 (en) 1995-03-02
NO960777D0 (no) 1996-02-26
CZ43896A3 (en) 1996-05-15
DE4328884A1 (de) 1995-03-02
BG100367A (en) 1996-07-31
CN1129906A (zh) 1996-08-28
EP0714301A1 (de) 1996-06-05
PL313116A1 (en) 1996-06-10
KR960703594A (ko) 1996-08-31
NO960777L (no) 1996-04-10

Similar Documents

Publication Publication Date Title
AU7672294A (en) Compositions and methods for the administration of delta-aminolevulinic acid
NZ250762A (en) Five-membered-heterocyclic carboxylic acid derivatives and pharmaceutical compositions
AU4893993A (en) Carboxylic acid derivatives
NZ222233A (en) 1,5-diphenylpyrazole derivatives and use as safeners for 2-phenoxypropionic acid ester herbicides
AU661018B2 (en) Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents
AU5230693A (en) Carboxylic acid derivatives
AU3020595A (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments
AU5184193A (en) Diaminobenzoic acid derivatives
AU1578692A (en) New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
AU649546B2 (en) Dicarboxylic acid derivatives and process for preparation thereof
HU9600322D0 (en) Novel quinolone carboxylic acid derivatives
AU1064895A (en) 3-methoxy-phenyl-acrylic acid methyl esters
AU4272793A (en) Novel quinolone carboxylic acid derivatives and process for preparing the same
AU6926294A (en) Carboxylic acid amide benzothiophene-s-oxides
AU3490389A (en) Intermediates for preparing 1,4-dihydro-4-oxo-quinoline-3-carboxylic acid esters
AU7613594A (en) Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments
AU4220293A (en) Process for preparing 10-deazaaminopterins and 5,10- and 8,10-dideazaaminopterins from pteroic dicarboxylic acid diesters
AU3011295A (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments
AU7534894A (en) 3-methoxy-2-phenylacrylic acid methyl esters
AU3108393A (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use
AU664084B2 (en) Novel thiosemicarbazonic acid esters
AU6205394A (en) Use of omega-guanidinocarboxylic acid esters
AU4355993A (en) Carboxylic acid derivative and production thereof
AU4164693A (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use
AU3233489A (en) Thionophosphonic acid(amide) esters